Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.
Publication
, Journal Article
Vlahovic, G; Fecci, PE; Reardon, D; Sampson, JH
Published in: Neuro Oncol
August 2015
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Neuro Oncol
DOI
EISSN
1523-5866
Publication Date
August 2015
Volume
17
Issue
8
Start / End Page
1043 / 1045
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Lymphocytes, Tumor-Infiltrating
- Humans
- Glioblastoma
- Brain Neoplasms
- B7-H1 Antigen
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Vlahovic, G., Fecci, P. E., Reardon, D., & Sampson, J. H. (2015). Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma. Neuro Oncol, 17(8), 1043–1045. https://doi.org/10.1093/neuonc/nov071
Vlahovic, Gordana, Peter E. Fecci, David Reardon, and John H. Sampson. “Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.” Neuro Oncol 17, no. 8 (August 2015): 1043–45. https://doi.org/10.1093/neuonc/nov071.
Vlahovic G, Fecci PE, Reardon D, Sampson JH. Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma. Neuro Oncol. 2015 Aug;17(8):1043–5.
Vlahovic, Gordana, et al. “Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.” Neuro Oncol, vol. 17, no. 8, Aug. 2015, pp. 1043–45. Pubmed, doi:10.1093/neuonc/nov071.
Vlahovic G, Fecci PE, Reardon D, Sampson JH. Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma. Neuro Oncol. 2015 Aug;17(8):1043–1045.
Published In
Neuro Oncol
DOI
EISSN
1523-5866
Publication Date
August 2015
Volume
17
Issue
8
Start / End Page
1043 / 1045
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Lymphocytes, Tumor-Infiltrating
- Humans
- Glioblastoma
- Brain Neoplasms
- B7-H1 Antigen
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences